Telehealth Evaluation
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Nottingham Primary Care Trust has launched telemonitoring to support: independent living and self-management ability of people with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) and co-morbidities; and reduce the health care utilisation associated with these patients, including the number of hospitalisations, GP visits and community matron and specialist community nurse home visits.
The Multidisciplinary Assessment of Technology Centre for Healthcare (MATCH) will evaluate the technology and its impact of this telemonitoring system on quality of care (i.e. process measures), patient outcomes and direct healthcare costs from an NHS perspective.
| Condition |
|---|
|
Congestive Heart Failure Chronic Obstructive Pulmonary Disease |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Evaluation of a Home-Based Telemonitor Service |
- Hospitalizations, hospital days, encounters with health professionals [ Time Frame: Collected until end date ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 500 |
| Study Start Date: | February 2009 |
| Estimated Study Completion Date: | February 2011 |
| Estimated Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
Group provided with home-based monitor
|
|
2
Group receives no home-based monitor
|
Detailed Description:
The study is designed to evaluate the impact of home-based monitoring to support community based nursing services and care matrons in the management of patients with CHF and COPD and co-morbidities. The main issue is to design a study that will determine the impact of the use of the technology independent of other factors. A randomised controlled trial has been chosen in which equal numbers of participants with and without home-based monitoring will be followed over the study to determine differences in utilisation of healthcare services including number of hospitalisations, length of stay in hospital, GP visits and community matron and specialist community nurse home visits.
The ethical issue is how to determine those that will receive home-based monitoring and those that will be denied. The study requires that participants are matched for severity of their condition in each arm and this could deny some from the potential benefits of monitoring. However, as only a limited number of home-based monitors are available and all participants will continue to receive normal health care services, we believe that those denied monitoring will not receive care that is different to patients not in the study and the ethical issues are acceptable.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Patients with congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) and co-morbidities referred to the community specialist nurse or care matron
Inclusion Criteria:
- Participants selected will be those: diagnosed with CHF, COPD or co-morbidities and referred to the community management service by its selection procedure for severity of the condition; are considered eligible for home-based telemonitoring; consent to receiving telemonitoring; have an active phone connection; are able to read and speak English (language of the equipment); are capable and willing to use the home monitoring device.
Exclusion Criteria:
- Patients are considered ineligible: if they have psychological or psychiatric disorders; if they have a cognitive deficiency that makes them unable to participate in their self-treatment; if they have a visual or motor deficiency that renders them incapable of using the telemonitoring device (unless a spouse or an informal caregiver is able to help); if they are currently scheduled for a hospital admission; if their life expectancy is shorter than 2 years; or if they already participate in another study.
Contacts and Locations| Contact: Malcolm Clarke, PhD | +44 1895 265053 | malcolm.clarke@brunel.ac.uk |
| United Kingdom | |
| Nottingham PCT | Not yet recruiting |
| Nottingham, Nottinghamshire, United Kingdom | |
| Contact: Malcolm Clarke, PhD +44 1895 265053 malcolm.clarke@brunel.ac.uk | |
| Principal Investigator: Malcolm Clarke, PhD | |
| Principal Investigator: | Malcolm Clarke, PhD | Brunel University |
More Information
No publications provided
| Responsible Party: | Malcolm Clarke, Brunel University |
| ClinicalTrials.gov Identifier: | NCT00789100 History of Changes |
| Other Study ID Numbers: | Nottingham-001 |
| Study First Received: | November 10, 2008 |
| Last Updated: | November 10, 2008 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by Brunel University:
|
telehealth telemonitor telemedicine Co-morbidities |
Additional relevant MeSH terms:
|
Heart Failure Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive |
Lung Diseases, Obstructive Heart Diseases Cardiovascular Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 23, 2013